Webinar with Dr Darrell DeMello — Highlights
We are pleased to present highlights of our webinar with Dr Darrell DeMello, who is one of these innovative medical doctors who has treated numerous
Tag: india
The Delta Variant & the Perfect Storm Looming over Canada (& Other Countries)
Today, COVID-19 cases in Canada are declining, from coast to coast, even if some lockdown restrictions remain in force. The summer is approaching and we
Professor Vikas Sukhatme Makes Outpatient Recommendation for India
Professor Vikas Sukhatme, the Dean of the School of Medicine at Emory University, got an article published today in The Times of India, presenting his
The 8th Day Therapy for COVID-19
This article is about the “8th Day Therapy” concept developed by Dr Shankara Chetty from South Africa, who has treated some 4,000 COVID-19 patients and
The COVID Crisis in India: an Interview with Dr Dhananjay Bakhle
Dr Dhananjay Bakhle, a physician treating COVID patients but also leading medical research for a pharmaceutical company, has agreed to respond to our questions regarding
The Practice of Early Outpatient Treatment
This is the full recording of our webinar with three distinguished medical doctors from South Africa, Canada and USA, about the practice of early outpatient
The Mystery Behind India’s Success in Flattening the Curve
Considering the burden on hospitals, the decision was made to treat the asymptomatic and mild cases at home and moderate and severe cases in the hospitals.
Avez-vous entendu parler de la thérapie ZIVERDO pour le COVID-19?
Ceci est un bref essai, une chaîne de pensées, d’une thérapie à 2 $ … à la chute des nations… (rien de moins! ) Article available
Did you Hear about the ZIVERDO Therapy for COVID-19?
This is a brief essay, a chain of thoughts, from a $2 therapy to … the fall of nations … (nothing less!) Article available in
HCQ in COVID-19 under Trial: With RCTs in Witness Box
Guest article by Dr Dhananjay Bakhle, Executive Vice President – Medical Research, Lupin. One of the most important aspects of a clinical trial publication is
Healthcare Workers Protected by HCQ Prophylaxis – Study
The study “Pre-exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers, by Bhattacharya and collaborators, found efficacy in pre-exposure prophylaxis for medical
New Prophylaxis Guidelines Issued in India Rely on Hydroxychloroquine
According to a May 22nd media release, the Joint Monitoring Group under the Chairmanship of DGHS and including representatives from AIIMS, ICMR, NCDC, NDMA, WHO
